Similar articles for PMID: 10797229

Year	Number of Results
1976	1
1978	1
1980	1
1982	1
1984	1
1985	3
1986	3
1987	3
1988	3
1989	5
1990	4
1991	4
1992	2
1993	7
1995	9
1996	5
1997	8
1998	4
1999	5
2000	8
2001	2
2002	6
2003	5
2004	11
2005	6
2006	10
2007	8
2008	6
2009	2
2010	4
2011	8
2012	9
2013	4
2014	2
2015	6
2016	8
2017	4
2018	3
2019	5
2020	6
2021	1
2022	3
2023	2
2024	0

1

Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.

Hruby VJ, Agnes RS. Hruby VJ, et al. Biopolymers. 1999;51(6):391-410. doi: 10.1002/(SICI)1097-0282(1999)51:6<391::AID-BIP3>3.0.CO;2-X. Biopolymers. 1999. PMID: 10797229 Review.

2

A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.

Watson B, Meng F, Akil H. Watson B, et al. Neurobiol Dis. 1996 Feb;3(1):87-96. doi: 10.1006/nbdi.1996.0009. Neurobiol Dis. 1996. PMID: 9173916

3

Dmt and opioid peptides: a potent alliance.

Bryant SD, Jinsmaa Y, Salvadori S, Okada Y, Lazarus LH. Bryant SD, et al. Biopolymers. 2003;71(2):86-102. doi: 10.1002/bip.10399. Biopolymers. 2003. PMID: 12767112 Review.

4

[Opioid receptors and their selective ligands].

Piestrzeniewicz MK, Fichna J, Janecka A. Piestrzeniewicz MK, et al. Postepy Biochem. 2006;52(3):313-9. Postepy Biochem. 2006. PMID: 17201067 Review. Polish.

5

Peptide and nonpeptide ligands for opioid receptors.

Misicka A. Misicka A. Acta Pol Pharm. 1995 Sep-Oct;52(5):349-63. Acta Pol Pharm. 1995. PMID: 8960271 Review.

6

Development of highly potent and selective dynorphin A analogues as new medicines.

Lung FD, Chen CH, Liu JH. Lung FD, et al. J Pept Res. 2005 Nov;66(5):263-76. doi: 10.1111/j.1399-3011.2005.00302.x. J Pept Res. 2005. PMID: 16218994

7

Recent advances in selective opioid receptor agonists and antagonists.

Eguchi M. Eguchi M. Med Res Rev. 2004 Mar;24(2):182-212. doi: 10.1002/med.10059. Med Res Rev. 2004. PMID: 14705168 Review.

8

The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.

Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, Chung NN. Schiller PW, et al. Biopolymers. 1999;51(6):411-25. doi: 10.1002/(SICI)1097-0282(1999)51:6<411::AID-BIP4>3.0.CO;2-Z. Biopolymers. 1999. PMID: 10797230 Review.

9

A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.

Shenderovich MD, Liao S, Qian X, Hruby VJ. Shenderovich MD, et al. Biopolymers. 2000 Jun;53(7):565-80. doi: 10.1002/(SICI)1097-0282(200006)53:7<565::AID-BIP4>3.0.CO;2-5. Biopolymers. 2000. PMID: 10766952

10

Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.

Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S. Ioja E, et al. Brain Res Bull. 2007 Sep 14;74(1-3):119-29. doi: 10.1016/j.brainresbull.2007.05.010. Epub 2007 Jun 8. Brain Res Bull. 2007. PMID: 17683797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

188 results

Results by year